Loading...

Thomas E Nordahl

Title(s)Professor Emeritus, Psychiatry and Behavioral Sciences
SchoolUniversity of California, Davis
vCardDownload vCard

    Collapse Research 
    Collapse Research Activities and Funding
    Neural Damage in Methamphetamine Users: An MRS Study
    NIH/NIDA R21DA014359Jun 1, 2002 - Feb 28, 2007
    Role: Principal Investigator
    HIPPOCAMPAL METABOLISM IN SCHIZOPHRENIA
    NIH/NIMH R29MH046990Sep 1, 1991 - Aug 31, 1996
    Role: Principal Investigator
    NIH INTRAMURAL NRSA INSTITUTIONAL TRAINING PROGRAM
    NIH/NIMH F35MH009453Jul 6, 1986
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Azarang A, Pakyurek M, Giroux C, Nordahl TE, Yellowlees P. Information Technologies: An Augmentation to Post-Traumatic Stress Disorder Treatment Among Trauma Survivors. Telemed J E Health. 2019 04; 25(4):263-271. PMID: 30004318.
      View in: PubMed
    2. Lissemore JI, Sookman D, Gravel P, Berney A, Barsoum A, Diksic M, Nordahl TE, Pinard G, Sibon I, Cottraux J, Leyton M, Benkelfat C. Brain serotonin synthesis capacity in obsessive-compulsive disorder: effects of cognitive behavioral therapy and sertraline. Transl Psychiatry. 2018 04 18; 8(1):82. PMID: 29666372.
      View in: PubMed
    3. Schaffer CB, Schaffer LC, Nordahl TE, Stark NM, Gohring CE. An Open Trial of Lurasidone as an Acute and Maintenance Adjunctive Treatment for Outpatients With Treatment-Resistant Bipolar Disorder: Response to Letter to the Editors. J Clin Psychopharmacol. 2016 Oct; 36(5):522-3. PMID: 27518477.
      View in: PubMed
    4. Schaffer CB, Schaffer LC, Nordahl TE, Stark NM, Gohring CE. An Open Trial of Lurasidone as an Acute and Maintenance Adjunctive Treatment for Outpatients With Treatment-Resistant Bipolar Disorder. J Clin Psychopharmacol. 2016 Feb; 36(1):88-9. PMID: 26650972.
      View in: PubMed
    5. Schaffer LC, Schaffer CB, Miller AR, Manley JL, Piekut JA, Nordahl TE. An open trial of pregabalin as an acute and maintenance adjunctive treatment for outpatients with treatment resistant bipolar disorder. J Affect Disord. 2013 May; 147(1-3):407-10. PMID: 23040739.
      View in: PubMed
    6. Berney A, Leyton M, Gravel P, Sibon I, Sookman D, Rosa Neto P, Diksic M, Nakai A, Pinard G, Todorov C, Okazawa H, Blier P, Nordahl TE, Benkelfat C. Brain regional a-[11C]methyl-L-tryptophan trapping in medication-free patients with obsessive-compulsive disorder. Arch Gen Psychiatry. 2011 Jul; 68(7):732-41. PMID: 21383250.
      View in: PubMed
    7. Salo R, Nordahl TE, Buonocore MH, Natsuaki YT, Moore CD, Waters C, Leamon MH. Spatial inhibition and the visual cortex: a magnetic resonance spectroscopy imaging study. Neuropsychologia. 2011 Apr; 49(5):830-838. PMID: 21237183.
      View in: PubMed
    8. Salo R, Flower K, Kielstein A, Leamon MH, Nordahl TE, Galloway GP. Psychiatric comorbidity in methamphetamine dependence. Psychiatry Res. 2011 Apr 30; 186(2-3):356-61. PMID: 21055832.
      View in: PubMed
    9. Salo R, Buonocore MH, Leamon M, Natsuaki Y, Waters C, Moore CD, Galloway GP, Nordahl TE. Extended findings of brain metabolite normalization in MA-dependent subjects across sustained abstinence: a proton MRS study. Drug Alcohol Depend. 2011 Jan 15; 113(2-3):133-8. PMID: 20739127.
      View in: PubMed
    10. Schaffer CB, Schaffer LC, Miller AR, Hang E, Nordahl TE. Efficacy and safety of nonbenzodiazepine hypnotics for chronic insomnia in patients with bipolar disorder. J Affect Disord. 2011 Feb; 128(3):305-8. PMID: 20701978.
      View in: PubMed
    11. Leamon MH, Flower K, Salo RE, Nordahl TE, Kranzler HR, Galloway GP. Methamphetamine and paranoia: the methamphetamine experience questionnaire. Am J Addict. 2010 Mar-Apr; 19(2):155-68. PMID: 20163388.
      View in: PubMed
    12. Salo R, Nordahl TE, Galloway GP, Moore CD, Waters C, Leamon MH. Drug abstinence and cognitive control in methamphetamine-dependent individuals. J Subst Abuse Treat. 2009 Oct; 37(3):292-7. PMID: 19339145.
      View in: PubMed
    13. Salo R, Nordahl TE, Buonocore MH, Natsuaki Y, Waters C, Moore CD, Galloway GP, Leamon MH. Cognitive control and white matter callosal microstructure in methamphetamine-dependent subjects: a diffusion tensor imaging study. Biol Psychiatry. 2009 Jan 15; 65(2):122-8. PMID: 18814867.
      View in: PubMed
    14. Salo R, Nordahl TE, Leamon MH, Natsuaki Y, Moore CD, Waters C, Carter CS. Preliminary evidence of behavioral predictors of recurrent drug-induced psychosis in methamphetamine abuse. Psychiatry Res. 2008 Jan 15; 157(1-3):273-7. PMID: 17928066.
      View in: PubMed
    15. Salo R, Leamon MH, Natsuaki Y, Moore C, Waters C, Nordahl TE. Findings of preserved implicit attention in methamphetamine dependent subjects. Prog Neuropsychopharmacol Biol Psychiatry. 2008 Jan 01; 32(1):217-23. PMID: 17870223.
      View in: PubMed
    16. Ravizza SM, Robertson LC, Carter CS, Nordahl TE, Salo RE. Is filtering difficulty the basis of attentional deficits in schizophrenia? Psychiatry Res. 2007 Jun 30; 151(3):201-9. PMID: 17399801.
      View in: PubMed
    17. Schaffer CB, Nordahl TE, Schaffer LC, Howe J. Mood-elevating effects of opioid analgesics in patients with bipolar disorder. J Neuropsychiatry Clin Neurosci. 2007; 19(4):449-52. PMID: 18070849.
      View in: PubMed
    18. Salo R, Nordahl TE, Natsuaki Y, Leamon MH, Galloway GP, Waters C, Moore CD, Buonocore MH. Attentional control and brain metabolite levels in methamphetamine abusers. Biol Psychiatry. 2007 Jun 01; 61(11):1272-80. PMID: 17097074.
      View in: PubMed
    19. Nordahl TE, Salo R, Natsuaki Y, Galloway GP, Waters C, Moore CD, Kile S, Buonocore MH. Methamphetamine users in sustained abstinence: a proton magnetic resonance spectroscopy study. Arch Gen Psychiatry. 2005 Apr; 62(4):444-52. PMID: 15809412.
      View in: PubMed
    20. Salo R, Nordahl TE, Moore C, Waters C, Natsuaki Y, Galloway GP, Kile S, Sullivan EV. A dissociation in attentional control: evidence from methamphetamine dependence. Biol Psychiatry. 2005 Feb 01; 57(3):310-3. PMID: 15691533.
      View in: PubMed
    21. Panizzon MS, Hoff AL, Nordahl TE, Kremen WS, Reisman B, Wieneke M, Harris D, Goodman C, Espinoza S, Liu W, Lim K. Sex differences in the corpus callosum of patients with schizophrenia. Schizophr Res. 2003 Jul 01; 62(1-2):115-22. PMID: 12765751.
      View in: PubMed
    22. Nordahl TE, Salo R, Leamon M. Neuropsychological effects of chronic methamphetamine use on neurotransmitters and cognition: a review. J Neuropsychiatry Clin Neurosci. 2003; 15(3):317-25. PMID: 12928507.
      View in: PubMed
    23. Nordahl TE, Salo R, Possin K, Gibson DR, Flynn N, Leamon M, Galloway GP, Pfefferbaum A, Spielman DM, Adalsteinsson E, Sullivan EV. Low N-acetyl-aspartate and high choline in the anterior cingulum of recently abstinent methamphetamine-dependent subjects: a preliminary proton MRS study. Magnetic resonance spectroscopy. Psychiatry Res. 2002 Nov 30; 116(1-2):43-52. PMID: 12426033.
      View in: PubMed
    24. Salo R, Henik A, Nordahl TE, Robertson LC. Time course of inhibition and facilitation in patients with schizophrenia. Cogn Neuropsychiatry. 2002 Nov; 7(4):283-300. PMID: 16571543.
      View in: PubMed
    25. Salo R, Henik A, Nordahl TE, Robertson LC. Immediate versus sustained processing in schizophrenia. J Int Neuropsychol Soc. 2002 Sep; 8(6):794-803. PMID: 12240743.
      View in: PubMed
    26. Salo R, Nordahl TE, Possin K, Leamon M, Gibson DR, Galloway GP, Flynn NM, Henik A, Pfefferbaum A, Sullivan EV. Preliminary evidence of reduced cognitive inhibition in methamphetamine-dependent individuals. Psychiatry Res. 2002 Aug 05; 111(1):65-74. PMID: 12140121.
      View in: PubMed
    27. Henik A, Carter CS, Salo R, Chaderjian M, Kraft L, Nordahl TE, Robertson LC. Attentional control and word inhibition in schizophrenia. Psychiatry Res. 2002 Jun 01; 110(2):137-49. PMID: 12057826.
      View in: PubMed
    28. Eberling JL, Roberts JA, Taylor SE, VanBrocklin HF, O'Neil JP, Nordahl TE. No effect of age and estrogen on aromatic L- amino acid decarboxylase activity in rhesus monkey brain. Neurobiol Aging. 2002 May-Jun; 23(3):479-83. PMID: 11959410.
      View in: PubMed
    29. Shuer ML. Neuropsychiatric testing and the menstrual cycle. Am J Psychiatry. 2002 Apr; 159(4):679-80; author reply 680. PMID: 11925326.
      View in: PubMed
    30. Nordahl TE, Carter CS, Salo RE, Kraft L, Baldo J, Salamat S, Robertson L, Kusubov N. Anterior cingulate metabolism correlates with stroop errors in paranoid schizophrenia patients. Neuropsychopharmacology. 2001 Jul; 25(1):139-48. PMID: 11377927.
      View in: PubMed
    31. Hoff AL, Kremen WS, Wieneke MH, Lauriello J, Blankfeld HM, Faustman WO, Csernansky JG, Nordahl TE. Association of estrogen levels with neuropsychological performance in women with schizophrenia. Am J Psychiatry. 2001 Jul; 158(7):1134-9. PMID: 11431236.
      View in: PubMed
    32. Peled A, Geva AB, Kremen WS, Blankfeld HM, Esfandiarfard R, Nordahl TE. Functional connectivity and working memory in schizophrenia: an EEG study. Int J Neurosci. 2001 Jan; 106(1-2):47-61. PMID: 11264908.
      View in: PubMed
    33. Cohen RM, Nordahl TE, Semple WE, Pickar D. The brain metabolic patterns of clozapine- and fluphenazine-treated female patients with schizophrenia: evidence of a sex effect. Neuropsychopharmacology. 1999 Nov; 21(5):632-40. PMID: 10516959.
      View in: PubMed
    34. Nordahl TE, Stein MB, Benkelfat C, Semple WE, Andreason P, Zametkin A, Uhde TW, Cohen RM. Regional cerebral metabolic asymmetries replicated in an independent group of patients with panic disorders. Biol Psychiatry. 1998 Nov 15; 44(10):998-1006. PMID: 9821564.
      View in: PubMed
    35. Cohen RM, Nordahl TE, Semple WE, Andreason P, Pickar D. Abnormalities in the distributed network of sustained attention predict neuroleptic treatment response in schizophrenia. Neuropsychopharmacology. 1998 Jul; 19(1):36-47. PMID: 9608575.
      View in: PubMed
    36. Murphy GM, Lim KO, Wieneke M, Ellis WG, Forno LS, Hoff AL, Nordahl T. No neuropathologic evidence for an increased frequency of Alzheimer's disease among elderly schizophrenics. Biol Psychiatry. 1998 Feb 01; 43(3):205-9. PMID: 9494702.
      View in: PubMed
    37. Salo R, Robertson LC, Nordahl TE, Kraft LW. The effects of antipsychotic medication on sequential inhibitory processes. J Abnorm Psychol. 1997 Nov; 106(4):639-43. PMID: 9358694.
      View in: PubMed
    38. Cohen RM, Nordahl TE, Semple WE, Andreason P, Litman RE, Pickar D. The brain metabolic patterns of clozapine- and fluphenazine-treated patients with schizophrenia during a continuous performance task. Arch Gen Psychiatry. 1997 May; 54(5):481-6. PMID: 9152102.
      View in: PubMed
    39. Nordahl TE, Kusubov N, Carter C, Salamat S, Cummings AM, O'Shora-Celaya L, Eberling J, Robertson L, Huesman RH, Jagust W, Budinger TF. Temporal lobe metabolic differences in medication-free outpatients with schizophrenia via the PET-600. Neuropsychopharmacology. 1996 Dec; 15(6):541-54. PMID: 8946428.
      View in: PubMed
    40. Carter C, Robertson L, Nordahl T, Chaderjian M, Kraft L, O'Shora-Celaya L. Spatial working memory deficits and their relationship to negative symptoms in unmedicated schizophrenia patients. Biol Psychiatry. 1996 Nov 01; 40(9):930-2. PMID: 8896783.
      View in: PubMed
    41. Carter CS, Robertson LC, Nordahl TE, Chaderjian M, Oshora-Celaya L. Perceptual and attentional asymmetries in schizophrenia: further evidence for a left hemisphere deficit. Psychiatry Res. 1996 May 17; 62(2):111-9. PMID: 8771608.
      View in: PubMed
    42. Salo R, Robertson LC, Nordahl TE. Normal sustained effects of selective attention are absent in schizophrenic patients withdrawn from medication. Psychiatry Res. 1996 May 17; 62(2):121-30. PMID: 8771609.
      View in: PubMed
    43. Eberling JL, Nordahl TE, Kusubov N, Reed BR, Budinger TF, Jagust WJ. Reduced temporal lobe glucose metabolism in aging. J Neuroimaging. 1995 Jul; 5(3):178-82. PMID: 7626826.
      View in: PubMed
    44. Carter CS, Robertson LC, Chaderjian MR, O'Shora-Celaya L, Nordahl TE. Attentional asymmetry in schizophrenia: the role of illness subtype and symptomatology. Prog Neuropsychopharmacol Biol Psychiatry. 1994 Jul; 18(4):661-83. PMID: 7938558.
      View in: PubMed
    45. Cohen RM, Gross M, Semple WE, Nordahl TE, Sunderland T. The metabolic brain pattern of young subjects given scopolamine. Exp Brain Res. 1994; 100(1):133-43. PMID: 7813641.
      View in: PubMed
    46. Jagust WJ, Eberling JL, Richardson BC, Reed BR, Baker MG, Nordahl TE, Budinger TF. The cortical topography of temporal lobe hypometabolism in early Alzheimer's disease. Brain Res. 1993 Dec 03; 629(2):189-98. PMID: 8111623.
      View in: PubMed
    47. Matthew E, Nordahl T, Schut L, King AC, Cohen R. Metabolic and cognitive changes in hereditary ataxia. J Neurol Sci. 1993 Nov; 119(2):134-40. PMID: 8277326.
      View in: PubMed
    48. Carter CS, Robertson LC, Nordahl TE, O'Shora-Celaya LJ, Chaderjian MC. Abnormal processing of irrelevant information in schizophrenia: the role of illness subtype. Psychiatry Res. 1993 Jul; 48(1):17-26. PMID: 8416015.
      View in: PubMed
    49. Matochik JA, Nordahl TE, Gross M, Semple WE, King AC, Cohen RM, Zametkin AJ. Effects of acute stimulant medication on cerebral metabolism in adults with hyperactivity. Neuropsychopharmacology. 1993 Jun; 8(4):377-86. PMID: 8512624.
      View in: PubMed
    50. Goyer PF, Schulz PM, Semple WE, Gross M, Nordahl TE, King AC, Wehr TA, Cohen RM. Cerebral glucose metabolism in patients with summer seasonal affective disorder. Neuropsychopharmacology. 1992 Nov; 7(3):233-40. PMID: 1388646.
      View in: PubMed
    51. Cohen RM, Gross M, Nordahl TE, Semple WE, Oren DA, Rosenthal N. Preliminary data on the metabolic brain pattern of patients with winter seasonal affective disorder. Arch Gen Psychiatry. 1992 Jul; 49(7):545-52. PMID: 1627045.
      View in: PubMed
    52. Carter CS, Robertson LC, Chaderjian MR, Celaya LJ, Nordahl TE. Attentional asymmetry in schizophrenia: controlled and automatic processes. Biol Psychiatry. 1992 May 01; 31(9):909-18. PMID: 1637931.
      View in: PubMed
    53. Carter CS, Robertson LC, Nordahl TE. Abnormal processing of irrelevant information in chronic schizophrenia: selective enhancement of Stroop facilitation. Psychiatry Res. 1992 Feb; 41(2):137-46. PMID: 1574540.
      View in: PubMed
    54. Cohen RM, Semple WE, Gross M, King AC, Nordahl TE. Metabolic brain pattern of sustained auditory discrimination. Exp Brain Res. 1992; 92(1):165-72. PMID: 1486951.
      View in: PubMed
    55. Benkelfat C, Mefford IN, Masters CF, Nordahl TE, King AC, Cohen RM, Murphy DL. Plasma catecholamines and their metabolites in obsessive-compulsive disorder. Psychiatry Res. 1991 Jun; 37(3):321-31. PMID: 1891512.
      View in: PubMed
    56. Zametkin AJ, Nordahl TE, Gross M, King AC, Semple WE, Rumsey J, Hamburger S, Cohen RM. Cerebral glucose metabolism in adults with hyperactivity of childhood onset. N Engl J Med. 1990 Nov 15; 323(20):1361-6. PMID: 2233902.
      View in: PubMed
    57. Benkelfat C, Nordahl TE, Semple WE, King AC, Murphy DL, Cohen RM. Local cerebral glucose metabolic rates in obsessive-compulsive disorder. Patients treated with clomipramine. Arch Gen Psychiatry. 1990 Sep; 47(9):840-8. PMID: 2393342.
      View in: PubMed
    58. Nordahl TE, Semple WE, Gross M, Mellman TA, Stein MB, Goyer P, King AC, Uhde TW, Cohen RM. Cerebral glucose metabolic differences in patients with panic disorder. Neuropsychopharmacology. 1990 Aug; 3(4):261-72. PMID: 2400544.
      View in: PubMed
    59. Cohen RM, Semple WE, Gross M, Nordahl TE, King AC, Pickar D, Post RM. Evidence for common alterations in cerebral glucose metabolism in major affective disorders and schizophrenia. Neuropsychopharmacology. 1989 Dec; 2(4):241-54. PMID: 2610821.
      View in: PubMed
    60. Nordahl TE, Benkelfat C, Semple WE, Gross M, King AC, Cohen RM. Cerebral glucose metabolic rates in obsessive compulsive disorder. Neuropsychopharmacology. 1989 Mar; 2(1):23-8. PMID: 2803479.
      View in: PubMed
    61. Cohen RM, Semple WE, Gross M, Nordahl TE, Holcomb HH, Dowling MS, Pickar D. The effect of neuroleptics on dysfunction in a prefrontal substrate of sustained attention in schizophrenia. Life Sci. 1988; 43(14):1141-50. PMID: 2902503.
      View in: PubMed
    62. Cohen RM, Semple WE, Gross M, Nordahl TE. From syndrome to illness: delineating the pathophysiology of schizophrenia with PET. Schizophr Bull. 1988; 14(2):169-76. PMID: 3059466.
      View in: PubMed
    63. Cohen RM, Semple WE, Gross M, Nordahl TE, DeLisi LE, Holcomb HH, King AC, Morihisa JM, Pickar D. Dysfunction in a prefrontal substrate of sustained attention in schizophrenia. Life Sci. 1987 May 18; 40(20):2031-9. PMID: 3494899.
      View in: PubMed